4//SEC Filing
Lalwani Narendra D. 4
Accession 0001179110-18-013333
CIK 0001434868other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 5:17 PM ET
Size
9.3 KB
Accession
0001179110-18-013333
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-28+8,000→ 8,000 totalExercise: $52.38Exp: 2028-11-28→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on February 28, 2019.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001615012
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 5:17 PM ET
- Size
- 9.3 KB